Emmanuel S. Antonarakis
Impact in
- Pulmonary and Respiratory Medicine top 0.02%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
Papers in
-
- Prostate Cancer Treatment and Research 306
- Prostate Cancer Diagnosis and Treatment 61
- Oncology 124
- Cancer Immunotherapy and Biomarkers 54
- PARP inhibition in cancer therapy 37
- Co-authors
- Mario A. Eisenberger (67 shared papers)Michael Anthony Carducci (55 shared papers)Jun Hui Luo (42 shared papers)Channing Judith Paller (34 shared papers)Ashkan Emadi (1 shared paper)Samuel Ray Denmeade (39 shared papers)Hao Wang (25 shared papers)Michael Thomas Schweizer (22 shared papers)
- Journals
- The Prostate (33 papers)Clinical Cancer Research (30 papers)Annals of Oncology (28 papers)European Urology (25 papers)Prostate Cancer and Prostatic Diseases (24 papers)
- Partner nations
- United StatesUnited KingdomBrazil
In The Last Decade
Emmanuel S. Antonarakis
441 papers receiving 27.8k citations
Emmanuel S. Antonarakis's Hit Papers
Peers
Comparison fields: 5 of 160
- Pulmonary and Respiratory Medicine 16.4k
- Cancer Research 7.4k
- Oncology 7.4k
- Radiology, Nuclear Medicine and Imaging 2.8k
- Molecular Biology 6.2k
Countries citing papers authored by Emmanuel S. Antonarakis
This map shows the geographic impact of Emmanuel S. Antonarakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel S. Antonarakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel S. Antonarakis more than expected).
Fields of papers citing papers by Emmanuel S. Antonarakis
This network shows the impact of papers produced by Emmanuel S. Antonarakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel S. Antonarakis. The network helps show where Emmanuel S. Antonarakis may publish in the future.
Co-authors
The 25 scholars most cited alongside Emmanuel S. Antonarakis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 460 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies Hit paper breakdown → | 2014 | 4133 |
| 2 | AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer Hit paper breakdown → | 2014 | 2229 |
| 3 | Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3 Hit paper breakdown → | 2016 | 1297 |
| 4 | Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2019 | 1263 |
| 5 | Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer Hit paper breakdown → | 2020 | 831 |
| 6 | Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study Hit paper breakdown → | 2019 | 565 |
| 7 | Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2015 | 527 |
| 8 | 2010 | 424 | |
| 9 | NCCN Guidelines Insights: Prostate Cancer, Version 1.2021 Hit paper breakdown → | 2021 | 416 |
| 10 | Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide Hit paper breakdown → | 2017 | 398 |
| 11 | Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer Hit paper breakdown → | 2015 | 380 |
| 12 | Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology Hit paper breakdown → | 2018 | 376 |
| 13 | Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study Hit paper breakdown → | 2019 | 307 |
| 14 | 2020 | 299 | |
| 15 | 2011 | 233 | |
| 16 | 2016 | 215 | |
| 17 | 2015 | 214 | |
| 18 | 2011 | 189 | |
| 19 | Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials Hit paper breakdown → | 2022 | 186 |
| 20 | 2017 | 183 |
About Emmanuel S. Antonarakis
Emmanuel S. Antonarakis is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism, having authored 460 papers that have together received 28.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (306 papers), Prostate Cancer Diagnosis and Treatment (61 papers), Cancer Immunotherapy and Biomarkers (54 papers), Radiopharmaceutical Chemistry and Applications (46 papers), PARP inhibition in cancer therapy (37 papers), Cancer, Lipids, and Metabolism (35 papers), Immunotherapy and Immune Responses (31 papers) and Hormonal and reproductive studies (31 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (16.4k citations), Cancer Research (7.4k citations), Oncology (7.4k citations), Radiology, Nuclear Medicine and Imaging (2.8k citations) and Molecular Biology (6.2k citations). Emmanuel S. Antonarakis has collaborated with scholars based in United States, United Kingdom and Brazil. Frequent co-authors include Mario A. Eisenberger, Michael Anthony Carducci, Jun Hui Luo, Channing Judith Paller, Ashkan Emadi, Samuel Ray Denmeade, Hao Wang, Michael Thomas Schweizer, Changxue Lu and Pedro Isaacsson Velho. Their work appears in journals such as The Prostate, Clinical Cancer Research, Annals of Oncology, European Urology and Prostate Cancer and Prostatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.